Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Apr 16;12(11):12234–12252. doi: 10.1002/cam4.5918

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2023 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.

This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Kaplan–Meier curves illustrating differences in prognosis in the subset of patients receiving ICI monotherapy. (A) PFS based on IL‐4 level at pretreatment. (B) PFS based on IL‐6 level at pretreatment. (C) PFS based on CCL11 level at pretreatment. (D) OS based on IL‐4 level at pretreatment. (E) OS based on IL‐6 level at pretreatment. (F) OS based on CCL11 level at pretreatment. (G) PFS based on change rate of IL‐6. (H) PFS based on change rate of IL‐8. (I) PFS based on change rate of CXCL10. (J) OS based on change rate of IL‐6. (K) OS based on change rate of IL‐8. (L) OS based on change rate of CXCL10. (M) PFS based on change rate of CCL5. (N) PFS based on change rate of CCR1. (O) OS based on change rate of CCL2. (P) OS based on change rate of CCL5. (Q) OS based on change rate of CCR1.